T. Rowe Price Associates’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $6.03M | Sell |
|
|||||
|
2023
Q3 | $7.08M | Sell |
|
|||||
|
2023
Q2 | $9.54M | Hold |
|
|||||
|
2023
Q1 | $9.48M | Hold |
|
|||||
|
2022
Q4 | $10.6M | Sell |
|
|||||
|
2022
Q3 | $8.1M | Hold |
|
|||||
|
2022
Q2 | $8.19M | Sell |
|
|||||
|
2022
Q1 | $53.8M | Sell |
|
|||||
|
2021
Q4 | $67.4M | Sell |
|
|||||
|
2021
Q3 | $79.1M | Sell |
|
|||||
|
2021
Q2 | $81.4M | Buy |
|
|||||
|
2021
Q1 | $64.1M | Buy |
|
|||||
|
2020
Q4 | $16.9M | Buy |
|
|||||
|
2020
Q3 | $5.58M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $438K | Buy |
|